Artigos de revistas sobre o tema "Allo-reactivity"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Allo-reactivity".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Huisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, J. H. Frederik Falkenburg e Inge Jedema. "The Scope of Allo-HLA Cross-Reactivity By (Third Party) Virus Specific T Cells Is Surprisingly Affected By HLA Restriction Rather Than Virus Specificity". Blood 132, Supplement 1 (29 de novembro de 2018): 2048. http://dx.doi.org/10.1182/blood-2018-99-116028.
Texto completo da fonteWebb, S. R., J. H. Li, I. MacNeil, P. Marrack, J. Sprent e D. B. Wilson. "T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes." Journal of Experimental Medicine 161, n.º 1 (1 de janeiro de 1985): 269–74. http://dx.doi.org/10.1084/jem.161.1.269.
Texto completo da fonteAmir, Avital L., Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate S. Hagedoorn, Renate de Boer, Menno A. W. G. van der Hoorn et al. "Allo-HLA reactivity of virus-specific memory T cells is common". Blood 115, n.º 15 (15 de abril de 2010): 3146–57. http://dx.doi.org/10.1182/blood-2009-07-234906.
Texto completo da fonteHuisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, Fred Falkenburg e Inge Jedema. "Off-Target HLA Cross-Reactivity By (Third Party) Virus-Specific T Cells Is Surprisingly Affected By HLA Restriction and HLA Background but Not By Virus Specificity". Blood 134, Supplement_1 (13 de novembro de 2019): 4440. http://dx.doi.org/10.1182/blood-2019-124785.
Texto completo da fonteHasenkamp, Justin, Andrea Borgerding, Bjoern Chapuy, Gerald Wulf, Inga Missal, Wolfram Jung, Lorenz Truemper e Bertram Glass. "Allo-Reactive NK Cells after HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation." Blood 108, n.º 11 (16 de novembro de 2006): 2904. http://dx.doi.org/10.1182/blood.v108.11.2904.2904.
Texto completo da fonteWebb, S. R., A. Okamoto e J. Sprent. "Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants." Journal of Immunology 141, n.º 6 (15 de setembro de 1988): 1828–34. http://dx.doi.org/10.4049/jimmunol.141.6.1828.
Texto completo da fonteElkon, Keith B., e Dalit Ash Any. "Autoimmunity Versus Allo- and Xeno-Reactivity in SCID Mice". International Reviews of Immunology 11, n.º 4 (janeiro de 1994): 283–93. http://dx.doi.org/10.3109/08830189409051175.
Texto completo da fonteLaghmouchi, Aicha, Conny Hoogstraten, Peter Van Balen, Rick van de Water, Marian van de Meent, J. H. Frederik Falkenburg e Inge Jedema. "The Allo-HLA-DP Restricted T Cell Repertoire Contains a Variety of Tissue-Restricted Specificities with Therapeutic Value". Blood 128, n.º 22 (2 de dezembro de 2016): 3356. http://dx.doi.org/10.1182/blood.v128.22.3356.3356.
Texto completo da fonteNoonan, Kimberly, Leo Luznik e Ivan M. Borrello. "Enrichment of Allogeneic Tumor Antigen-Specific T Cells From Bone Marrow (BM) of Patients Treated with High-Dose Post-Transplant Cyclophoshamide (Cy) – A Novel Approach to Adoptive Immunotherapy". Blood 118, n.º 21 (18 de novembro de 2011): 647. http://dx.doi.org/10.1182/blood.v118.21.647.647.
Texto completo da fonteD’Orsogna, Lloyd, Heleen van den Heuvel, Cees van Kooten, Sebastiaan Heidt e Frans H. J. Claas. "Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms". Immunogenetics 69, n.º 8-9 (17 de julho de 2017): 631–41. http://dx.doi.org/10.1007/s00251-017-0989-3.
Texto completo da fonteByun, Nari, Hyun-Je Kim, Il-Hee Yoon e Oh-Sang Kwon. "Cross reactivity of allo and xenoimmune response in transplantation (TRAN2P.964)". Journal of Immunology 194, n.º 1_Supplement (1 de maio de 2015): 209.4. http://dx.doi.org/10.4049/jimmunol.194.supp.209.4.
Texto completo da fonteHueso, Thomas, Leonardo Magro, Marie Jonquel-chevalier Curt, Ibrahim Yakoub-Agha e David Seguy. "Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD". Blood 128, n.º 22 (2 de dezembro de 2016): 4592. http://dx.doi.org/10.1182/blood.v128.22.4592.4592.
Texto completo da fonteBurkhardt, Ute E., Ursula Hainz, Kristen E. Stevenson, Di Wu, Vincent T. Ho, Natalie R. Goldstein, Mildred Pasek et al. "Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL)". Blood 120, n.º 21 (16 de novembro de 2012): 1892. http://dx.doi.org/10.1182/blood.v120.21.1892.1892.
Texto completo da fonteten Berge, Ineke, Kirstin Heutinck, Unsal Yapici, Geurt Stokman, Sandrine Florquin, Cees van Kooten, G. Garcia-Romo et al. "The interplay between antiviral immunity and allo-immune reactivity after renal transplantation". Transplant Immunology 31, n.º 4 (outubro de 2014): 191–94. http://dx.doi.org/10.1016/j.trim.2014.09.004.
Texto completo da fonteKarahan, Gonca E., Frans H. J. Claas e Sebastiaan Heidt. "Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ Transplantation". Viruses 13, n.º 12 (24 de novembro de 2021): 2359. http://dx.doi.org/10.3390/v13122359.
Texto completo da fonteBondanza, Attilio, Veronica Valtolina, Zulma Magnani, Maurilio Ponzoni, Katharina Fleischhauer, Mark Bonyhadi, Catia Traversari et al. "Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes". Blood 107, n.º 5 (1 de março de 2006): 1828–36. http://dx.doi.org/10.1182/blood-2005-09-3716.
Texto completo da fonteAmir, Avital L., Dirk M. van der Steen, Renate S. Hagedoorn, Michel G. D. Kester, Cornelis A. M. van Bergen, Jan W. Drijfhout, Arnoud H. de Ru, J. H. Frederik Falkenburg, Peter A. van Veelen e Mirjam H. M. Heemskerk. "Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific". Blood 118, n.º 26 (22 de dezembro de 2011): 6733–42. http://dx.doi.org/10.1182/blood-2011-05-354787.
Texto completo da fonteKuball, Jürgen, Wouter Scheper, Suzanne van Dorp, Sabina Kersting, Floor Pietersma, Samantha Hol, Victoria Marcu-Malina, Sabine Becke, Bodo Plachter e Debbie van Baarle. "Multipotent Vδ2-negative γδT-cells after CMV-reactivation in allogeneic stem cell transplantation (162.36)". Journal of Immunology 188, n.º 1_Supplement (1 de maio de 2012): 162.36. http://dx.doi.org/10.4049/jimmunol.188.supp.162.36.
Texto completo da fonteBondanza, Attilio, Veronica Valtolina, Zulma Magnani, Shin Kaneko, Maurilio Ponzoni, Francesca Sanvito, Mark Bonyhadi et al. "Suicide Gene Therapy of Graft-Versus-Host Disease Induced by Central Memory Human T Lymphocytes." Blood 106, n.º 11 (16 de novembro de 2005): 3096. http://dx.doi.org/10.1182/blood.v106.11.3096.3096.
Texto completo da fonteKarmaus, W., e V. Gangur. "Does allo-immune reactivity play a role in the prenatal programming of childhood allergy?" Clinical Experimental Allergy 35, n.º 4 (abril de 2005): 405–7. http://dx.doi.org/10.1111/j.1365-2222.2005.02218.x.
Texto completo da fonteMarkiewicz, Miroslaw, Urszula Siekiera, Tomasz Kruzel, Monika Dzierzak-Mietla, Patrycja Zielinska e Slawomira Kyrcz-Krzemien. "DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors." Blood 116, n.º 21 (19 de novembro de 2010): 4575. http://dx.doi.org/10.1182/blood.v116.21.4575.4575.
Texto completo da fonteUdaka, K., K. H. Wiesmüller, S. Kienle, G. Jung e P. Walden. "Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone." Journal of Immunology 157, n.º 2 (15 de julho de 1996): 670–78. http://dx.doi.org/10.4049/jimmunol.157.2.670.
Texto completo da fonteKlobuch, Sebastian, Kathrin Hammon, Sarah Vatter-Leising, Elisabeth Neidlinger, Michael Zwerger, Annika Wandel, Laura Maria Neuber et al. "HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation". Cells 9, n.º 5 (20 de maio de 2020): 1264. http://dx.doi.org/10.3390/cells9051264.
Texto completo da fonteAdam, Jacqueline, Natascha Wuillemin, Stephan Watkins, Heidi Jamin, Klara K. Eriksson, Peter Villiger, Stefano Fontana, Werner J. Pichler e Daniel Yerly. "Abacavir Induced T Cell Reactivity from Drug Naïve Individuals Shares Features of Allo-Immune Responses". PLoS ONE 9, n.º 4 (21 de abril de 2014): e95339. http://dx.doi.org/10.1371/journal.pone.0095339.
Texto completo da fontePearson, Todd, Marie King, Leonard Shultz, Jean Leif, Dale Greiner, John Mordes, Aldo Rossini et al. "Development of Latest-generation HU-PBMC-NOD/SCID Mice to Study Human Islet Allo-reactivity". Clinical Immunology 123 (2007): S69. http://dx.doi.org/10.1016/j.clim.2007.03.374.
Texto completo da fonteTawara, Isao, Kana Okamori, Naoyuki Katayama, Hiroshi Shiku e Hiroaki Ikeda. "Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation". Blood 128, n.º 22 (2 de dezembro de 2016): 2157. http://dx.doi.org/10.1182/blood.v128.22.2157.2157.
Texto completo da fonteJürgens, Birgit, Julia Raberger, Dietmar Fuchs e Andreas Heitger. "Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation". International Journal of Tryptophan Research 3 (janeiro de 2010): IJTR.S4076. http://dx.doi.org/10.4137/ijtr.s4076.
Texto completo da fontevan Bergen, Cornelis A. M., Simone A. P. Van Luxemburg-Heijs, Matthijs Eefting, Maria W. Honders, Inge Jedema, Constantijn J. M. Halkes, Marieke Griffioen e J. H. Frederik Falkenburg. "Graft Versus Leukemia Separates From Graft Versus Host Disease By Magnitude and Avidity Of The Allo-Reactive T Cell Response After Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion". Blood 122, n.º 21 (15 de novembro de 2013): 2014. http://dx.doi.org/10.1182/blood.v122.21.2014.2014.
Texto completo da fonteMielke, Stephan, Raquel Nunes, Katayoun Rezvani, Vicki S. Fellowes, Yong Fan, Scott R. Solomon, Christian Scotto, Elizabeth J. Read e A. John Barrett. "High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs." Blood 108, n.º 11 (16 de novembro de 2006): 721. http://dx.doi.org/10.1182/blood.v108.11.721.721.
Texto completo da fonteDavid, V., J. F. Bourge, P. Guglielmi, D. Mathieu-Mahul, L. Degos e A. Bensussan. "Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity." Journal of Immunology 138, n.º 9 (1 de maio de 1987): 2831–36. http://dx.doi.org/10.4049/jimmunol.138.9.2831.
Texto completo da fonteRowntree, Louise C., Thi H. O. Nguyen, Stephanie Gras, Tom C. Kotsimbos e Nicole A. Mifsud. "Deciphering the clinical relevance of allo-human leukocyte antigen cross-reactivity in mediating alloimmunity following transplantation". Current Opinion in Organ Transplantation 21, n.º 1 (fevereiro de 2016): 29–39. http://dx.doi.org/10.1097/mot.0000000000000264.
Texto completo da fonteGamadia, Laila E., Ester B. Remmerswaal, Sugianto Surachno, Neubury M. Lardy, Pauline M. Wertheim-van Dillen, Ren?? A. W. van Lier e Ineke J. M. ten Berge. "CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES". Transplantation 77, n.º 12 (junho de 2004): 1879–85. http://dx.doi.org/10.1097/01.tp.0000131158.81346.64.
Texto completo da fonteQureshi, Khalid M., Jou Lee, Michelle B. Paget, Clifford J. Bailey, S. John Curnow, Hilary E. Murray e Richard Downing. "Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity". Clinical Transplantation 29, n.º 1 (5 de dezembro de 2014): 90–98. http://dx.doi.org/10.1111/ctr.12488.
Texto completo da fonteMethe, Heiko, Adam Groothuis, Mohamed H. Sayegh e Elazer R. Edelman. "Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo‐ and xenogeneic models". FASEB Journal 21, n.º 7 (30 de janeiro de 2007): 1515–26. http://dx.doi.org/10.1096/fj.06-7051com.
Texto completo da fonteD’Orsogna, Lloyd J., Frans H. J. Claas, Mina John, Coral-Ann Almeida, Paula van Miert, Sonia Fernandez e Yvonne Zoet. "OR24 Allo-HLA reactivity by HIV-specific T-cells: A potential adjunct to HIV vaccine design?" Human Immunology 76 (outubro de 2015): 9. http://dx.doi.org/10.1016/j.humimm.2015.07.016.
Texto completo da fonteSommer, Cesar, Bijan Boldajipour, Julien Valton, Roman Galetto, Trevor Bentley, Janette Sutton, Yajin Ni et al. "ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma". Blood 132, Supplement 1 (29 de novembro de 2018): 591. http://dx.doi.org/10.1182/blood-2018-99-119227.
Texto completo da fonteCousens, Leslie P., e Pamela A. Davol. "Targeting Lymphoma with Bispecific Antibody-Armed T Cells and their Potential for use in an Allogeneic Setting (41.31)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 41.31. http://dx.doi.org/10.4049/jimmunol.182.supp.41.31.
Texto completo da fonteMorse, H. C., R. A. Yetter, C. S. Via, R. R. Hardy, A. Cerny, K. Hayakawa, A. W. Hugin, M. W. Miller, K. L. Holmes e G. M. Shearer. "Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome." Journal of Immunology 143, n.º 3 (1 de agosto de 1989): 844–50. http://dx.doi.org/10.4049/jimmunol.143.3.844.
Texto completo da fonteRaghunathan, R., T. M. Mundy, J. Faust e S. Misra. "Allogeneic leukocyte and germ cell-induced murine immunodeficiency." Journal of Immunology 135, n.º 4 (1 de outubro de 1985): 2429–31. http://dx.doi.org/10.4049/jimmunol.135.4.2429.
Texto completo da fonteYao, Xin, Fenlu Zhu, Huiqing Xu e Carolyn A. Keever-Taylor. "Allo-Reactive Potential of Multi-Virus Specific Cytotoxic T Cell Lines Recognizing Adenovirus Hexon, Cytomegalovirus pp65 and Epstein Barr Virus." Blood 114, n.º 22 (20 de novembro de 2009): 5121. http://dx.doi.org/10.1182/blood.v114.22.5121.5121.
Texto completo da fonteCastro, Januario E., Juan S. Barajas-Gamboa, Julio A. Diaz-Perez, Lina M. Ariza-Serrano, Sue Corringham, Thomas J. Kipps e Edward D. Ball. "Improved Outcome in Unrelated Donor Recipients After Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Advanced Relapse / Refractory Chronic Lymphocytic Leukemia". Blood 118, n.º 21 (18 de novembro de 2011): 4474. http://dx.doi.org/10.1182/blood.v118.21.4474.4474.
Texto completo da fonteMelenhorst, J. Joseph, Ann M. Leen, Catherine M. Bollard, Máire F. Quigley, David A. Price, Cliona M. Rooney, Malcolm K. Brenner, A. John Barrett e Helen E. Heslop. "Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects". Blood 116, n.º 22 (25 de novembro de 2010): 4700–4702. http://dx.doi.org/10.1182/blood-2010-06-289991.
Texto completo da fonteSommer, Cesar, Hsin-Yuan Cheng, Yik Andy Yeung, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton et al. "Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia". Blood 134, Supplement_1 (13 de novembro de 2019): 3921. http://dx.doi.org/10.1182/blood-2019-129025.
Texto completo da fonteBlomberg, B. B., S. Hussini, H. Fainman, J. M. Mathew, A. Hernandez, M. Carreno, H. J. Hnatyszyn et al. "Retroviral transduction of an allogeneic class II gene into human bone marrow down regulates allo-immune reactivity". Human Immunology 64, n.º 10 (outubro de 2003): S128. http://dx.doi.org/10.1016/j.humimm.2003.08.240.
Texto completo da fonteAmir, Avital, Marieke Griffioen, Michel D. G. Kester, M. Willy Honders, Roelof Willemze, J. H. Frederik Falkenburg e Mirjam Heemskerk. "Allo-HLA Reactive CD8 T-Cells May Recognize Tissue Specific Peptides Explaining Tissue Restricted GVHD after HLA Mismatched SCT." Blood 110, n.º 11 (16 de novembro de 2007): 72. http://dx.doi.org/10.1182/blood.v110.11.72.72.
Texto completo da fonteStevanovic, Sanja, Bart Nijmeijer, Marianke LJ Van Schie, Roelof Willemze, Marieke Griffioen e J. H. Frederik Falkenburg. "Human T Cells with Distinct Specificities Mediate Graft-Versus-Leukemia Reactivity and Xenogeneic Graft-Versus-Host Disease in a NOD/Scid Mouse Model for Human Acute Leukemia." Blood 114, n.º 22 (20 de novembro de 2009): 1330. http://dx.doi.org/10.1182/blood.v114.22.1330.1330.
Texto completo da fonteFirer, Michael A., Sofi Yado, Luboshits Galia e Reuven Or. "A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease". Blood 132, Supplement 1 (29 de novembro de 2018): 3339. http://dx.doi.org/10.1182/blood-2018-99-110292.
Texto completo da fonteBurrack, Adam, Maki Nakayama, Laurie Landry, Marilyne Coulombe e Ronald Gill. "Autoimmunity as an endogenous source of heterologous alloimmunity (TRAN3P.868)". Journal of Immunology 192, n.º 1_Supplement (1 de maio de 2014): 202.7. http://dx.doi.org/10.4049/jimmunol.192.supp.202.7.
Texto completo da fontePilunov, Artem, Dmitrii S. Romaniuk, Anton Shmelev, Savely Sheetikov, Anna N. Gabashvili, Alexandra Khmelevskaya, Dmitry Dianov et al. "Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells". Cancers 15, n.º 5 (3 de março de 2023): 1592. http://dx.doi.org/10.3390/cancers15051592.
Texto completo da fonteStaba, Susan Lynn, Melissa Reese e Joanne Kurtzberg. "Immunophenotype and Analysis of Allo-Reactivity of Umbilical Cord Blood (UCB)-Derived T-Cells Following Ex-Vivo Expansion." Blood 104, n.º 11 (16 de novembro de 2004): 403. http://dx.doi.org/10.1182/blood.v104.11.403.403.
Texto completo da fonte